Latest Stock Split Details
Key information about Protagenic Therapeutics, Inc.'s most recent stock split
Split Date: 2025-05-05
Split Ratio: 1:14
Price Before Split: $0.20
Price After Split: $0.01
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 14.00 times fewer shares (a 1:14 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Protagenic Therapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2025-05-05 | 1:14 | Yes | $0.20 | $0.01 |
| 2023-03-23 | 1:4 | Yes | $0.43 | $0.11 |
| 2017-01-11 | 1:15464 | Yes | $0.00 | $0.00 |
| 2016-07-27 | 1:15464 | Yes | $0.00 | $0.00 |
| 2010-12-03 | 1:4 | Yes | $0.00 | $0.00 |
| 2007-05-03 | 1:300 | Yes | $0.00 | $0.00 |
About Protagenic Therapeutics, Inc.
Company overview and industry information
Protagenic Therapeutics, Inc. (PTIX) operates in the Biotechnology industry. The recent 1-for-14 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Protagenic Therapeutics, Inc. Summary